Microfluidic Technologies in Advancing Cancer Research
2024
Microfluidic Technologies in Advancing Cancer Research
publication
Evidence: high
Author Information
Author(s): Ajikumar Arjun, Lei Kin Fong
Primary Institution: Chang Gung University, Taiwan
Conclusion
Microfluidic technologies are transforming cancer research by enabling personalized treatments and addressing challenges in scalability, cost, and clinical integration.
Supporting Evidence
- Microfluidic technologies allow precise manipulation of cells and tissues.
- Organ-on-chip systems replicate human organs for drug testing.
- Paper-based microfluidics provide low-cost diagnostic solutions.
- Electrokinetic chips enable precise control over cell behavior.
- Microfluidic platforms facilitate real-time observation of immune responses.
Takeaway
This study shows how tiny devices can help scientists understand cancer better and create treatments that work for individual patients.
Methodology
The review discusses various microfluidic technologies including droplet-based microfluidics, organ-on-chip systems, paper-based microfluidics, electrokinetic chips, and immune response analysis.
Limitations
Challenges include complexity, cost, and scalability of microfluidic technologies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website